Cargando…

Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization

Background: Major challenges in the application of intensity-modulated proton therapy (IMPT) for lung cancer patients include the uncertainties associated with breathing motion, its mitigation and its consideration in IMPT optimization. The primary objective of this research was to evaluate the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Shuaiping, Wang, Xiaochun, Liao, Zhongxing, Zhang, Lifei, Sahoo, Narayan, Yang, Jinzhong, Guan, Fada, Mohan, Radhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356681/
https://www.ncbi.nlm.nih.gov/pubmed/30609652
http://dx.doi.org/10.3390/cancers11010035
_version_ 1783391608517951488
author Ge, Shuaiping
Wang, Xiaochun
Liao, Zhongxing
Zhang, Lifei
Sahoo, Narayan
Yang, Jinzhong
Guan, Fada
Mohan, Radhe
author_facet Ge, Shuaiping
Wang, Xiaochun
Liao, Zhongxing
Zhang, Lifei
Sahoo, Narayan
Yang, Jinzhong
Guan, Fada
Mohan, Radhe
author_sort Ge, Shuaiping
collection PubMed
description Background: Major challenges in the application of intensity-modulated proton therapy (IMPT) for lung cancer patients include the uncertainties associated with breathing motion, its mitigation and its consideration in IMPT optimization. The primary objective of this research was to evaluate the potential of four-dimensional robust optimization (4DRO) methodology to make IMPT dose distributions resilient to respiratory motion as well as to setup and range uncertainties; Methods: The effect of respiratory motion, characterized by different phases of 4D computed tomography (4DCT), was incorporated into an in-house 4DRO system. Dose distributions from multiple setup and range uncertainty scenarios were calculated for each of the ten phases of CT datasets. The 4DRO algorithm optimizes dose distributions to achieve target dose coverage and normal tissue sparing for multiple setup and range uncertainty scenarios as well as for all ten respiratory phases simultaneously. IMPT dose distributions of ten lung cancer patients with different tumor sizes and motion magnitudes were optimized to illustrate our approach and its potential; Results: Compared with treatment plans generated using the conventional planning target volume (PTV)-based optimization and 3D robust optimization (3DRO), plans generated by 4DRO were found to have superior clinical target volume coverage and dose robustness in the face of setup and range uncertainties as well as for respiratory motion. In most of the cases we studied, 4DRO also resulted in more homogeneous target dose distributions. Interestingly, such improvements were found even for cases in which moving diaphragms intruded into the proton beam paths; Conclusion: The incorporation of respiratory motion, along with setup and range uncertainties, into robust optimization, has the potential to improve the resilience of target and normal tissue dose distributions in IMPT plans in the face of the uncertainties considered. Moreover, it improves the optimality of plans compared to PTV-based optimization as well as 3DRO.
format Online
Article
Text
id pubmed-6356681
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63566812019-02-05 Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization Ge, Shuaiping Wang, Xiaochun Liao, Zhongxing Zhang, Lifei Sahoo, Narayan Yang, Jinzhong Guan, Fada Mohan, Radhe Cancers (Basel) Article Background: Major challenges in the application of intensity-modulated proton therapy (IMPT) for lung cancer patients include the uncertainties associated with breathing motion, its mitigation and its consideration in IMPT optimization. The primary objective of this research was to evaluate the potential of four-dimensional robust optimization (4DRO) methodology to make IMPT dose distributions resilient to respiratory motion as well as to setup and range uncertainties; Methods: The effect of respiratory motion, characterized by different phases of 4D computed tomography (4DCT), was incorporated into an in-house 4DRO system. Dose distributions from multiple setup and range uncertainty scenarios were calculated for each of the ten phases of CT datasets. The 4DRO algorithm optimizes dose distributions to achieve target dose coverage and normal tissue sparing for multiple setup and range uncertainty scenarios as well as for all ten respiratory phases simultaneously. IMPT dose distributions of ten lung cancer patients with different tumor sizes and motion magnitudes were optimized to illustrate our approach and its potential; Results: Compared with treatment plans generated using the conventional planning target volume (PTV)-based optimization and 3D robust optimization (3DRO), plans generated by 4DRO were found to have superior clinical target volume coverage and dose robustness in the face of setup and range uncertainties as well as for respiratory motion. In most of the cases we studied, 4DRO also resulted in more homogeneous target dose distributions. Interestingly, such improvements were found even for cases in which moving diaphragms intruded into the proton beam paths; Conclusion: The incorporation of respiratory motion, along with setup and range uncertainties, into robust optimization, has the potential to improve the resilience of target and normal tissue dose distributions in IMPT plans in the face of the uncertainties considered. Moreover, it improves the optimality of plans compared to PTV-based optimization as well as 3DRO. MDPI 2019-01-01 /pmc/articles/PMC6356681/ /pubmed/30609652 http://dx.doi.org/10.3390/cancers11010035 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ge, Shuaiping
Wang, Xiaochun
Liao, Zhongxing
Zhang, Lifei
Sahoo, Narayan
Yang, Jinzhong
Guan, Fada
Mohan, Radhe
Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
title Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
title_full Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
title_fullStr Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
title_full_unstemmed Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
title_short Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
title_sort potential for improvements in robustness and optimality of intensity-modulated proton therapy for lung cancer with 4-dimensional robust optimization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356681/
https://www.ncbi.nlm.nih.gov/pubmed/30609652
http://dx.doi.org/10.3390/cancers11010035
work_keys_str_mv AT geshuaiping potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT wangxiaochun potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT liaozhongxing potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT zhanglifei potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT sahoonarayan potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT yangjinzhong potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT guanfada potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization
AT mohanradhe potentialforimprovementsinrobustnessandoptimalityofintensitymodulatedprotontherapyforlungcancerwith4dimensionalrobustoptimization